Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...

This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly ...

Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...

Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment is expected to be ...

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.39, marking a -6.71% move from the previous day. The stock's performance was behind the S&P 500's daily gain of ...

Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!

The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...

Ben Lamm, CEO of Colossal Biosciences, wanted to ensure his brand was approachable to all, fun, educational and full of ...